Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2291-2301

  Kim, Young June ^a   Park, Su Jung ^a   Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD200 RECEPTOR; CD86 ANTIGEN; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; PROGRAMMED CELL DEATH 1 LIGAND; PROGRAMMED DEATH 1 RECEPTOR; PROGRAMMED DEATH 2 RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CLEARANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE COUNT; MACROPHAGE; MYELOID DERIVED SUPPRESSOR CELL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUPPRESSOR CELL;

ANTIGENS, CD; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; LIGANDS; MACROPHAGE COLONY-STIMULATING FACTOR; MICROSCOPY, CONFOCAL; MYELOID CELLS; PHAGOCYTOSIS;

EID: 80052677358     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002650     Document Type: Article

References (59)

1. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. Van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927. (Pubitemid 36402840)
2. Shin, H., and E. J. Wherry. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19: 408-415. (Pubitemid 47284857)
3. + T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
4. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704. (Pubitemid 351600389)
5. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29-37.
6. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
7. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81: 4215-4225. (Pubitemid 46586915)
8. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
9. Curiel, T. J., S. Wei, H. Dong, X. Alvarez, P. Cheng, P. Mottram, R. Krzysiek, K. L. Knutson, B. Daniel, M. C. Zimmermann, et al. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9: 562-567. (Pubitemid 36597102)
10. Zou, W., and L. Chen. 2008. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8: 467-477. (Pubitemid 351733418)
11. Chen, L. 2004. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347. (Pubitemid 38649276)
12. Butte, M. J., M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122. (Pubitemid 47089023)
13. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
14. Wang, X., Z. Zhang, S. Zhang, J. Fu, J. Yao, Y. Jiao, H. Wu, and F. S. Wang. 2008. B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection. Eur. J. Immunol. 38: 3226-3236.
15. Trabattoni, D., M. Saresella, M. Biasin, A. Boasso, L. Piacentini, P. Ferrante, H. Dong, R. Maserati, G. M. Shearer, L. Chen, and M. Clerici. 2003. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101: 2514-2520. (Pubitemid 36857606)
16. + T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6: 280-286.
17. +T cell responses to antigen in lymph nodes and tissues. J. Immunol. 179: 5064-5070.
18. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206: 3015-3029.
19. Thompson, R. H., H. Dong, C. M. Lohse, B. C. Leibovich, M. L. Blute, J. C. Cheville, and E. D. Kwon. 2007. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin. Cancer Res. 13: 1757-1761. (Pubitemid 46952942)
20. + T lymphocytes are prognostic factors of human ovarian cancer. Proc. Natl. Acad. Sci. USA 104: 3360-3365.
21. Zou, W. 2005. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5: 263-274. (Pubitemid 40488632)
22. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
23. Marigo, I., L. Dolcetti, P. Serafini, P. Zanovello, and V. Bronte. 2008. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222: 162-179. (Pubitemid 351430364)
24. Greifenberg, V., E. Ribechini, S. Rössner, and M. B. Lutz. 2009. Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development. Eur. J. Immunol. 39: 2865-2876.
25. Steinbrink, K., K. Mahnke, S. Grabbe, A. H. Enk, and H. Jonuleit. 2009. Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance? Hum. Immunol. 70: 289-293.
26. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
27. +) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92: 4778-4791.
28. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
29. Brem-Exner, B. G., C. Sattler, J. A. Hutchinson, G. E. Koehl, K. Kronenberg, S. Farkas, S. Inoue, C. Blank, S. J. Knechtle, H. J. Schlitt, et al. 2008. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J. Immunol. 180: 335-349.
30. Liu, Y., B. Zeng, Z. Zhang, Y. Zhang, and R. Yang. 2008. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clin. Immunol. 129: 471-481.
31. Ilkovitch, D., and D. M. Lopez. 2009. The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res. 69: 5514-5521.
32. Brooks, D. G., S. J. Ha, H. Elsaesser, A. H. Sharpe, G. J. Freeman, and M. B. Oldstone. 2008. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc. Natl. Acad. Sci. USA 105: 20428-20433.
33. Filippi, C. M., and M. G. Von Herrath. 2008. IL-10 and the resolution of infections. J. Pathol. 214: 224-230. (Pubitemid 351160159)
34. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. Von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472. (Pubitemid 44664616)
35. Clerici, M., T. A. Wynn, J. A. Berzofsky, S. P. Blatt, C. W. Hendrix, A. Sher, R. L. Coffman, and G. M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93: 768-775. (Pubitemid 24072820)
36. Rigopoulou, E. I., W. G. Abbott, P. Haigh, and N. V. Naoumov. 2005. Blocking of interleukin-10 receptor-a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 117: 57-64. (Pubitemid 41725470)
37. + monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels. J. Viral Hepat. 13: 725-733.
38. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
39. Martinic, M. M., and M. G. Von Herrath. 2008. Novel strategies to eliminate persistent viral infections. Trends Immunol. 29: 116-124.
40. absentdendritic cells with tolerogenic potential. J. Immunol. 174: 4706-4717.
41. Xu, W., A. Roos, N. Schlagwein, A. M. Woltman, M. R. Daha, and C. Van Kooten. 2006. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107: 4930-4937. (Pubitemid 43882647)
42. Blackburn, S. D., A. Crawford, H. Shin, A. Polley, G. J. Freeman, and E. J. Wherry. 2010. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J. Virol. 84: 2078-2089.
43. Gorczynski, R. M. 2005. CD200 and its receptors as targets for immunoregulation. Curr. Opin. Investig. Drugs 6: 483-488. (Pubitemid 40613969)
44. Wong, K. K., I. Khatri, S. Shaha, D. E. Spaner, and R. M. Gorczynski. 2010. The role of CD200 in immunity to B cell lymphoma. J. Leukoc. Biol. 88: 361-372.
45. Sato, K., K. Eizumi, T. Fukaya, S. Fujita, Y. Sato, H. Takagi, M. Yamamoto, N. Yamashita, A. Hijikata, H. Kitamura, et al. 2009. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood 113: 4780-4789.
46. Gorczynski, R. M., Z. Chen, W. He, I. Khatri, Y. Sun, K. Yu, and I. Boudakov. 2009. Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J. Immunol. 183: 1560-1568.
47. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779. (Pubitemid 32983013)
48. Platt, C. D., J. K. Ma, C. Chalouni, M. Ebersold, H. Bou-Reslan, R. A. D. Carano, I. Mellman, and L. Delamarre. 2010. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc. Natl. Acad. Sci. USA 107: 4287-4292.
49. + T cells. J. Immunol. 184: 1765-1775.
50. Bronte, V. 2009. Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 39: 2670-2672.
51. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245. (Pubitemid 46745373)
52. Asavaroengchai, W., H. Wang, S. Wang, L. Wang, R. Bronson, M. Sykes, and Y. G. Yang. 2007. An essential role for IFN-γ in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 13: 46-55. (Pubitemid 46044099)
53. Dong, H., G. Zhu, K. Tamada, D. B. Flies, J. M. Van Deursen, and L. Chen. 2004. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20: 327-336. (Pubitemid 38388234)
54. Gallina, G., L. Dolcetti, P. Serafini, C. De Santo, I. Marigo, M. P. Colombo, G. Basso, F. Brombacher, I. Borrello, P. Zanovello, et al. 2006. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+T cells. J. Clin. Invest. 116: 2777-2790. (Pubitemid 44511641)
55. Koning, N., M. Van Eijk, W. Pouwels, M. S. Brouwer, D. Voehringer, I. Huitinga, R. M. Hoek, G. Raes, and J. Hamann. 2010. Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J. Innate Immun. 2: 195-200.
56. Clark, D. A., G. Chaouat, K. Wong, R. M. Gorczynski, and R. Kinsky. 2010. Tolerance mechanisms in pregnancy: a reappraisal of the role of class I paternal MHC antigens. Am. J. Reprod. Immunol. 63: 93-103.
57. Heikkinen, J., M. Möttönen, J. Komi, A. Alanen, and O. Lassila. 2003. Phenotypic characterization of human decidual macrophages. Clin. Exp. Immunol. 131: 498-505. (Pubitemid 36324142)
58. Gustafsson, C., J. Mjösberg, A. Matussek, R. Geffers, L. Matthiesen, G. Berg, S. Sharma, J. Buer, and J. Ernerudh. 2008. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS ONE 3: e2078.
59. + myelomonocytic cells results in induction of Tregs and immunosuppression. Proc. Natl. Acad. Sci. USA 107: 11918-11923.